The Changing Treatment Landscape for Metastatic Urothelial Carcinoma
This information was originally presented at the NCCN 23rd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care held in Orlando, Florida, from March 22 - 24, 2018.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Immunotherapies in Metastatic Bladder Cancer
Join Sherry Mori Vogt, PharmD, BCOP from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute for this webinar in the 2018 NCCN Pharmacy Update Webinar Series on the topic Immunotherapies in Metastatic Bladder Cancer.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Bladder Cancer
Advances in the Treatment of Muscle-Invasive Bladder Cancer
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Bladder Cancer, Version 5.2018
The NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer.
Category
  • Bladder Cancer
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation